blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3154595

EP3154595 - TREATING MYELOMAS [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  30.04.2021
Database last updated on 03.09.2024
FormerExamination is in progress
Status updated on  03.04.2019
FormerRequest for examination was made
Status updated on  20.03.2017
FormerThe international publication has been made
Status updated on  21.12.2016
Most recent event   Tooltip30.04.2021Refusal of applicationpublished on 02.06.2021  [2021/22]
Applicant(s)For all designated states
Mayo Foundation for Medical Education and Research
200 First Street S.W.
Rochester, MN 55905 / US
[2017/16]
Inventor(s)01 / MARKOVIC, Svetomir N.
1320 Creek Lane S.W.
Rochester, Minnesota 55902 / US
02 / NEVALA, Wendy K.
71 N. River Court N.E.
Rochester, Minnesota 55906 / US
 [2017/16]
Representative(s)Lloyd, John Scott
Script IP Limited
Turnpike House
18 Bridge Street
Frome Somerset BA11 1BB / GB
[N/P]
Former [2017/16]Gibson, Mark
Sagittarius IP
Three Globeside
Fieldhouse Lane
Marlow, Buckinghamshire SL7 1HZ / GB
Application number, filing date15809075.312.06.2015
[2017/16]
WO2015US35515
Priority number, dateUS201462012804P16.06.2014         Original published format: US 201462012804 P
[2017/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015195476
Date:23.12.2015
Language:EN
[2015/51]
Type: A1 Application with search report 
No.:EP3154595
Date:19.04.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 23.12.2015 takes the place of the publication of the European patent application.
[2017/16]
Search report(s)International search report - published on:US23.12.2015
(Supplementary) European search report - dispatched on:EP21.12.2017
ClassificationIPC:A61P35/00, A61K31/337, A61K47/64, A61K39/395
[2018/04]
CPC:
A61K47/6849 (EP,KR,US); A61K9/5169 (EP,KR,US); A61K31/337 (EP,KR,US);
A61K47/643 (EP,KR,US); A61K9/0019 (EP,KR,US); A61P19/00 (EP);
A61P31/00 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P7/00 (EP) (-)
Former IPC [2017/16]A61K47/50, A61P31/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/16]
TitleGerman:BEHANDLUNG VON MYELOMEN[2017/16]
English:TREATING MYELOMAS[2017/16]
French:TRAITEMENT DE MYÉLOMES[2017/16]
Entry into regional phase21.12.2016National basic fee paid 
21.12.2016Search fee paid 
21.12.2016Designation fee(s) paid 
21.12.2016Examination fee paid 
Examination procedure21.12.2016Examination requested  [2017/16]
21.12.2016Date on which the examining division has become responsible
17.07.2018Amendment by applicant (claims and/or description)
08.04.2019Despatch of a communication from the examining division (Time limit: M04)
12.08.2019Reply to a communication from the examining division
23.11.2020Cancellation of oral proceeding that was planned for 24.11.2020
24.11.2020Date of oral proceedings (cancelled)
20.01.2021Despatch of communication that the application is refused, reason: substantive examination [2021/22]
30.01.2021Application refused, date of legal effect [2021/22]
Divisional application(s)EP20209622.8
Fees paidRenewal fee
16.06.2017Renewal fee patent year 03
27.06.2018Renewal fee patent year 04
27.06.2019Renewal fee patent year 05
29.06.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2010092489  (VAN DE WINKEL JAN [NL], et al) [A] 1-15* claims 1, 53 *;
 [Y]WO2012088388  (MAYO FOUNDATION [US], et al) [Y] 1-15 * example 1; claims 1-18 *;
 [Y]US2014161819  (HANN BYRON C [US], et al) [Y] 1-15 * figure 12; example 3; claims 1-4 *
International search[Y]US2011262525  (WANG YAN [US], et al) [Y] 20, 21, 46, 47* ; paragraphs [0123], [0236] *;
 [Y]WO2014009774  (HANGZHOU DAC BIOTECH CO LTD [CN], et al) [Y] 1-72 * ; page 36, lines 5-10; page 42, lines 15-20; page 46, lines 30-35; page 47, lines 10-15; page 55, lines 15-25; page 57, lines 30-35; page 61, lines 5-15 *;
 [Y]WO2014055415  (MAYO FOUNDATION [US]) [Y] 1-72 * ; page 2, lines 10-20; page 3, lines 5-10; page 3, lines 20-31; page 4, lines 10-20; page 5, lines 15-30 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.